journal article·2012-12-01

Creating a bio-hybrid signal transduction pathway: opening a new channel of communication between cells and machines

Orr Yarkoni, Lynn Donlon, Daniel Frankel

Bioinspiration & Biomimetics· Volume 7· Issue 4
Publisher page

Abstract

Manipulation of signal transduction pathways presents a viable mechanism to interface cells with electronics. In this work, we present a two-step signal transduction pathway involving cellular and electronic transduction elements. In order to circumvent many of the conventional difficulties encountered when harnessing chemical signalling for the purpose of electronics communication, gaseous nitric oxide (NO) was selected as the signalling molecule. By genetic engineering of the nitric oxide synthase protein eNOS and insertion of light-oxygen-voltage (LOV) domains, we have created a photoactive version of the protein. The novel chimeric eNOS was found to be capable of producing NO in response to excitation by visible light. By coupling these mutant cells to a surface modified platinum electrode, it was possible to convert an optical signal into a chemical one, followed by subsequent conversion of the chemical signal into an electrical output.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Photoreceptor and optogenetics research · Neuroscience and Neural Engineering · Electrochemical sensors and biosensors

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (35)

Show source-provided references
1. 10.1098/rsta.2006.191010.1098/rsta.2006.1910 ↗
2. 10.1080/1176232090324484310.1080/11762320903244843 ↗
3. Hu J · IEEE Circuits Syst. · 2010 · 53 · 541
4. 10.1038/8435910.1038/84359 ↗
5. 10.1007/s00216-004-2512-610.1007/s00216-004-2512-6 ↗
6. Beckman J S · Am. J. Physiol. · 1996 · 271 · 142410.1152/ajpcell.1996.271.5.C1424 ↗
7. 10.1529/biophysj.107.12062610.1529/biophysj.107.120626 ↗
8. 10.1016/S0891-5849(01)00781-X10.1016/S0891-5849(01)00781-X ↗
9. 10.1073/pnas.91.17.813710.1073/pnas.91.17.8137 ↗
10. 10.1007/BF0317985510.1007/BF03179855 ↗
11. Iadecola C · Am. J. Physiol. Integr. Comput. Physiol. · 1993 · 264 · 73810.1152/ajpregu.1993.264.4.R738 ↗
12. 10.1016/S1360-1385(01)01893-310.1016/S1360-1385(01)01893-3 ↗
13. 10.1006/niox.2000.028010.1006/niox.2000.0280 ↗
14. 10.1016/j.pharmthera.2004.06.00410.1016/j.pharmthera.2004.06.004 ↗
15. 10.1016/j.mce.2010.07.01010.1016/j.mce.2010.07.010 ↗
16. 10.1016/j.elecom.2005.12.00910.1016/j.elecom.2005.12.009 ↗
17. 10.1042/0264-6021:357059310.1042/0264-6021:3570593 ↗
18. 10.1074/jbc.272.2.127610.1074/jbc.272.2.1276 ↗
19. Fulton D · Pharmacology · 2001 · 299 · 818
20. Kone B C · Ren. Physiol. · 2003 · 285 · 17810.1152/ajprenal.00048.2003 ↗
21. 10.1073/pnas.92.25.1177610.1073/pnas.92.25.11776 ↗
22. 10.1172/JCI11975010.1172/JCI119750 ↗
23. Farstermann U · Naunyn-Schmiedebergs Arch. Pharmacol. · 1995 · 352 · 351
24. 10.1007/s11120-008-9367-110.1007/s11120-008-9367-1 ↗
25. Crosson S · DNA Repair · 2003 · 42 · 2
26. 10.1021/ja983309f10.1021/ja983309f ↗
27. 10.1016/j.jphotochem.2007.02.00710.1016/j.jphotochem.2007.02.007 ↗
28. 10.1016/S0039-9140(03)00354-010.1016/S0039-9140(03)00354-0 ↗
29. 10.1046/j.1469-8137.2003.00804.x10.1046/j.1469-8137.2003.00804.x ↗
30. 10.1073/pnas.89.14.634810.1073/pnas.89.14.6348 ↗
31. 10.1016/S1388-2481(02)00489-710.1016/S1388-2481(02)00489-7 ↗
32. 10.1016/j.bios.2005.02.01510.1016/j.bios.2005.02.015 ↗
33. 10.1016/S0927-7765(99)00148-410.1016/S0927-7765(99)00148-4 ↗
34. 10.1016/S0925-4005(99)00027-110.1016/S0925-4005(99)00027-1 ↗
35. 10.1016/S0956-5663(97)00038-910.1016/S0956-5663(97)00038-9 ↗